FogPharma, based in Cambridge, Mass., was founded in 2016 by several scientists including Gregory Verdine, the company’s chairman and CEO, Weiging Zhou, David Lane, and Gerard Hilinski. The company, which was valued at $406 million in November 2022, is developing a new class of drugs designed to treat cancerous tumors that have remained elusive to other approaches.
In November 2022, FogPharma closed a $178 million Series D round led by a group of investors including Arch Venture Partners and Invus.
These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
FogPharma is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
FogPharma has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.
FogPharma is privately held company and is not publicly traded, therefor investing in FogPharma pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.
To determine the value of your FogPharma shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your FogPharma shares. You can also learn more about how to sell your private shares before getting started.
Yes, you can seek to sell shares in FogPharma while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.
Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
---|---|---|---|---|
3/1/2024 | Series E |
$145MM raised | $XXX.XX | $XXX.XX |
11/21/2022 | Series D |
$178MM raised | $XXX.XX | $XXX.XX |
3/1/2021 | Series C |
$107MM raised | $XXX.XX | $XXX.XX |
5/16/2018 | Series B |
$65.51MM raised | $XXX.XX | $XXX.XX |
5/25/2016 | Series A |
$11.11MM raised | $XXX.XX | $XXX.XX |